Insuficiencia hepática fulminante / Fulminant hepatic failure
Rev. méd. Chile
;
130(6): 691-698, jun. 2002. tab, graf
Artigo
em Espanhol
| LILACS
| ID: lil-317503
RESUMO
Fulminant hepatic failure (FHF) is an acute and eventually fatal illness, caused by a severe hepatocyte damage with massive necrosis. Its hallmarks are hepatic encephalopathy and a prolonged prothrombin time (<40 percent). FHF is currently defined as hyperacute (encephalopathy appearing within 7 days of the onset of jaundice), acute (encephalopathy appearing between 8 and 28 days) or subacute (encephalopathy appearing between 5 and 12 weeks). FHF can be caused by viruses, drugs, toxins, and miscellaneous conditions such as Wilson's disease, Budd-Chiari syndrome, ischemia and others. However, a single most common etiology is still not defined. Factors that are valuable in assessing the likelihood of spontaneous recovery are age, etiology, degree of encephalopathy, prothrombin time and serum bilirubin. The management is based in the early treatment of infections, hemodynamic abnormalities, cerebral edema, and other associated conditions. Liver transplant has emerged as the most important advance in the therapy of FHF, with a survival rate that ranges between 60 and 80 percent. The use of hepatic support systems, extracorporeal liver support and auxiliary liver transplantation are innovative therapies
Texto completo:
DisponíveL
Índice:
LILACS (Américas)
Assunto principal:
Transplante de Fígado
/
Insuficiência Hepática
Tipo de estudo:
Estudo de etiologia
Limite:
Humanos
Idioma:
Espanhol
Revista:
Rev. méd. Chile
Assunto da revista:
Medicina
Ano de publicação:
2002
Tipo de documento:
Artigo
País de afiliação:
Chile
Instituição/País de afiliação:
Universidad de Chile/CL
Similares
MEDLINE
...
LILACS
LIS